Abstract
The official variations of status epilepticus (SE) International League Against Epilepsy (ILAE, 2015) diagnostic criteria and the non-convulsive SE (NCSE) Salzburg Consensus Criteria (2013), impose the collection of updated population-based epidemiological Italian data. In this study, we aimed at evaluating (a) the frequency of SE in our hospital adopting the new ILAE 2015 SE diagnostic criteria and NCSE Salzburg Consensus Criteria, (b) the frequency of adherence to current treatment guidelines for SE and their relationship with patients’ outcome, and (c) reliability of standardized prognostic scales (Status Epilepticus Severity Score—STESS—and modified STESS) for short-term outcome prediction in the setting of the newest diagnostic criteria for SE and NCSE. Detailed clinical and electrophysiological data collected in a 1-year retrospective hospital-based single-center survey on SE at Parma Hospital, Northern Italy are provided. Non-adherence to current treatment guidelines was recorded in around 50% cases, but no relation to outcome was appreciated. Mortality in our cohort increased from 30 to 50% when follow-up was extended to 30 days. STESS score was strongly correlated with short-term mortality risk (OR 18.9, 2.2–163.5, CI), and we confirm its role as easy-to-use tool for outcome evaluation also when the new ILAE diagnostic SE criteria are applied.
Similar content being viewed by others
References
Logroscino G, Hesdorffer DC, Cascino G, Hauser WA, Coeytaux A, Galobardes B et al (2005) Mortality after a first episode of status epilepticus in the United States and Europe. Epilepsia 46(Suppl 11):46–48. https://doi.org/10.1111/j.1528-1167.2005.00409.x
Vignatelli L, Rinaldi R, Galeotti M, de Carolis P, D’Alessandro R (2005) Epidemiology of status epilepticus in a rural area of northern Italy: a 2-year population-based study. Eur J Neurol 12(11):897–902. https://doi.org/10.1111/j.1468-1331.2005.01073.x
Vignatelli L, Tonon C, D’Alessandro R, Bologna Group for the Study of Status Epilepticus (2003) Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia 44(7):964–8. https://doi.org/10.1046/j.1528-1157.2003.63702.x
Coeytaux A, Jallon P, Galobardes B, Morabia A (2000) Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 55(5):693–697. https://doi.org/10.1212/wnl.55.5.693
DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG (1995) Epidemiology of status epilepticus. J Clin Neurophysiol 12(4):316–325
Hauser WA (1990) Status epilepticus: epidemiologic considerations. Neurology 40(5 Suppl 2):9–13
Szucs A, Barcs G, Jakus R, Rásonyi G, Lalit N, Holló A et al (2008) Late-life absence status epilepticus: a female disorder? Epileptic Disord 10(2):156–161. https://doi.org/10.1684/epd.2008.0186
Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA (1997) Short-term mortality after a first episode of status epilepticus. Epilepsia 38(12):1344–1349. https://doi.org/10.1111/j.1528-1157.1997.tb00073.x
Atmaca MM, Bebek N, Baykan B, Gökyiğit A, Gürses C (2017) Predictors of outcomes and refractoriness in status epilepticus: a prospective study. Epilepsy Behav 75:158–164. https://doi.org/10.1016/j.yebeh.2017.07.046
Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB (2006) Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 77(5):611–615. https://doi.org/10.1136/jnnp.2005.080887
Spatola M, Alvarez V, Rossetti AO (2013) Benzodiazepine overtreatment in status epilepticus is related to higher need of intubation and longer hospitalization. Epilepsia 54(8):e99–e102. https://doi.org/10.1111/epi.12235
Scholtes FB, Renier WO, Meinardi H (1994) Generalized convulsive status epilepticus: causes, therapy, and outcome in 346 patients. Epilepsia 35(5):1104–12. https://doi.org/10.1111/j.1528-1157.1994.tb02562.x
Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J et al (2016) Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr 16(1):48–61. https://doi.org/10.5698/1535-7597-16.1.48
Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB (2008) Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol 255(10):1561–1566. https://doi.org/10.1007/s00415-008-0989-1
González-Cuevas M, Santamarina E, Toledo M, Quintana M, Sala J, Sueiras M, Guzman L et al (2016) A new clinical score for the prognosis of status epilepticus in adults. Eur J Neurol 23(10):1534–1540. https://doi.org/10.1111/ene.13073
Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S et al (2015) A definition and classification of status epilepticus–report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 56(10):1515–1523. https://doi.org/10.1111/epi.13121
Hirsch LJ, LaRoche SM, Gaspard N, Gerard E, Svoronos A, Herman ST et al (2013) American Clinical Neurophysiology Society’s Standardized Critical Care EEG Terminology: 2012 version. J Clin Neurophysiol 30(1):1–27. https://doi.org/10.1097/WNP.0b013e3182784729
Trinka E, Leitinger M (2015) Which EEG patterns in coma are nonconvulsive status epilepticus? Epilepsy Behav 49:203–222. https://doi.org/10.1016/j.yebeh.2015.05.005
Leitinger M, Beniczky S, Rohracher A, Gardella E, Kalss G, Qerama E et al (2015) Salzburg Consensus Criteria for Non-Convulsive Status Epilepticus–approach to clinical application. Epilepsy Behav 49:158–163. https://doi.org/10.1016/j.yebeh.2015.05.007
Ferlisi M, Shorvon S (2012) The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 135(Pt 8):2314–28. https://doi.org/10.1093/brain/aws091. Epub 2012 May 9. Erratum in: Brain. 2013 Jul;136(Pt 7):2326
Leitinger M, Trinka E, Giovannini G, Zimmermann G, Florea C, Rohracher A et al (2019) Epidemiology of status epilepticus in adults: a population-based study on incidence, causes, and outcomes. Epilepsia 60(1):53–62. https://doi.org/10.1111/epi.14607
Tanaka T, Ihara M (2017) Post-stroke epilepsy. Neurochem Int 107:219–228. https://doi.org/10.1016/j.neuint.2017.02.002
Santarone ME, Pietrafusa N, Fusco L (2020) Neonatal seizures: when semiology points to etiology. Seizure 80:161–165. https://doi.org/10.1016/j.seizure.2020.06.025
Sutter R, Rüegg S, Kaplan PW (2012) Epidemiology, diagnosis, and management of nonconvulsive status epilepticus: opening Pandora’s box. Neurol Clin Pract 2(4):275–286. https://doi.org/10.1212/CPJ.0b013e318278be75
Koren JP, Herta J, Pirker S, Fürbass F, Hartmann M, Kluge T et al (2016) Rhythmic and periodic EEG patterns of ‘ictal-interictal uncertainty’ in critically ill neurological patients. Clin Neurophysiol 127(2):1176–1181. https://doi.org/10.1016/j.clinph.2015.09.135
Punia V, Garcia CG, Hantus S (2015) Incidence of recurrent seizures following hospital discharge in patients with LPDs (PLEDs) and nonconvulsive seizures recorded on continuous EEG in the critical care setting. Epilepsy Behav 49:250–254. https://doi.org/10.1016/j.yebeh.2015.06.026
Koren J, Herta J, Draschtak S, Pötzl G, Pirker S, Fürbass F et al (2015) Prediction of rhythmic and periodic EEG patterns and seizures on continuous EEG with early epileptiform discharges. Epilepsy Behav 49:286–289. https://doi.org/10.1016/j.yebeh.2015.04.044
Naylor DE, Liu H, Wasterlain CG (2005) Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci 25(34):7724–7733. https://doi.org/10.1523/JNEUROSCI.4944-04.2005
Brigo F, Lattanzi S, Nardone R, Trinka E (2019) Intravenous brivaracetam in the treatment of status epilepticus: a systematic review. CNS Drugs 33(8):771–781. https://doi.org/10.1007/s40263-019-00652-0
Shorvon S, Ferlisi M (2011) The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 134(Pt 10):2802–2818. https://doi.org/10.1093/brain/awr215
Uppal P, Cardamone M, Lawson JA (2018) Outcomes of deviation from treatment guidelines in status epilepticus: a systematic review. Seizure 58:147–153. https://doi.org/10.1016/j.seizure.2018.04.005
Strzelczyk A, Steinig I, Willems LM, Reif PS, Senft C, Voss M et al (2017) Treatment of refractory and super-refractory status epilepticus with brivaracetam: a cohort study from two German university hospitals. Epilepsy Behav 70(Pt A):177–181. https://doi.org/10.1016/j.yebeh.2017.03.028
Strzelczyk A, Kay L, Bauer S, Immisch I, Klein KM, Knake S et al (2018) Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus. Epilepsia 59(8):1549–1556. https://doi.org/10.1111/epi.14476
Kalss G, Rohracher A, Leitinger M, Pilz G, Novak HF, Neuray C et al (2018) Intravenous brivaracetam in status epilepticus: a retrospective single-center study. Epilepsia 59(Suppl 2):228–233. https://doi.org/10.1111/epi.14486
Strzelczyk A, Knake S, Kälviäinen R, Santamarina E, Toledo M, Willig S et al (2019) Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain. Acta Neurol Scand 139(4):369–376. https://doi.org/10.1111/ane.13061
Orlandi N, Bartolini E, Audenino D, ColettiMoja M, Urso L, d’Orsi G et al (2021) Intravenous brivaracetam in status epilepticus: a multicentric retrospective study in Italy. Seizure 86:70–76. https://doi.org/10.1016/j.seizure.2021.01.014
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors. The study was approved by the Local Ethical Committee.
Informed consent
Informed consent was requested and collected, where applicable, for all participants.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Highlights
• Updated informations on status epilepticus epidemiology applying ILAE 2015 diagnostic criteria and 2013 Salzburg consensus criteria for NCSE are provided.
• STESS is a quick-to-use prognostic scale useful in everyday clinical practice to support the clinician decision-making process.
• Ictal semiology may vary according to underlying acute versus remote SE etiology.
• Female sex, older age, personal history of epilepsy, remote symptomatic SE and rapid antiepiletic withdrawal could increase the risk for praecox SE relapse.
Rights and permissions
About this article
Cite this article
Mutti, C., Sansonetti, A., Monti, G. et al. Epidemiology, management and outcome of status epilepticus in adults: single-center Italian survey. Neurol Sci 43, 2003–2013 (2022). https://doi.org/10.1007/s10072-021-05572-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-021-05572-w